China Universal Asset Management Company’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.15K Sell
37,352
-3,722
-9% -$1.04K ﹤0.01% 508
2026
Q1
$13.5K Sell
41,074
-6,642
-14% -$10.4K ﹤0.01% 498
2025
Q4
$148K Buy
+47,716
New +$136K 0.01% 377
2023
Q4
Sell
-5,774
Closed -$4.81K 451
2023
Q3
$4.81K Buy
5,774
+4,523
+362% +$5.21K ﹤0.01% 395
2023
Q2
$1.5K Sell
1,251
-29
-2% -$36 ﹤0.01% 441
2023
Q1
$1.61K Buy
1,280
+320
+33% +$613 ﹤0.01% 439
2022
Q4
$2.08K Buy
960
+80
+9% +$659 ﹤0.01% 369
2022
Q3
$11K Buy
+880
New +$10.9K ﹤0.01% 196

Other funds holding GOSS

China Universal Asset Management Company's GOSS Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Gossamer Bio (GOSS) stake by 9.1% in Q2 2026, selling an estimated $1.04K and leaving 37,352 shares worth $6.15K. The position accounts for ﹤0.01% of the portfolio, ranked #508.

China Universal Asset Management Company first reported a position in GOSS in Q3 2022 and has held it in 8 quarters since. The position peaked at $148K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • China Universal Asset Management Company held 37,352 shares of Gossamer Bio worth $6.15K as of Q2 2026.
  • China Universal Asset Management Company sold 3,722 Gossamer Bio shares in Q2 2026, an estimated $1.04K.
  • Gossamer Bio made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #508 holding.
  • China Universal Asset Management Company first reported a position in Gossamer Bio in Q3 2022 and has held it in 8 quarters since.
  • China Universal Asset Management Company's Gossamer Bio position peaked at $148K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.